Lv12
72 积分 2024-09-06 加入
Metabolomics and lipidomics predictor of survival in hepatocellular carcinoma patients receiving tyrosine kinase inhibitor and immune checkpoint inhibitor combination therapy
11天前
已完结
Distinct follicular T cell subsets regulate lymphoma progression and outcomes
5个月前
已完结
Mobilizing antigen-presenting mast cells in anti-PD-1-refractory triple-negative breast cancer: a phase 2 trial
5个月前
已完结
Liver tumour immune microenvironment subtypes and neutrophil heterogeneity
6个月前
已完结
皖公网安备34019202002308
